Clinical Trial

Study of STLX-2012 in Healthy Volunteers

Name: Study of STLX-2012 in Healthy Volunteers — clinical trial record (NCT07231744)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this research is to establish the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single IV dose of STLX-2012.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-14.

Trial Details

NCT Number	NCT07231744
Lead Sponsor	Stelexis BioSciences
Conditions	Healthy Participants
Enrollment	32 participants
Start Date	2026-10
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-22